Related Experiment Videos

Early primary repair of tetralogy of Fallot

R A Gustafson1, G F Murray, H E Warden

  • 1Department of Surgery, West Virginia University Medical Center, Morgantown 26505.

Insights

Primary intracardiac repair of tetralogy of Fallot is safe and effective for symptomatic children, regardless of age or weight. This study found no deaths and good long-term outcomes, even with transannular patch use.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Tetralogy of Fallot Repair

Background:

  • Young age, low weight, and transannular patch reconstruction for the right ventricular outflow tract (RVOT) are traditionally considered risk factors for tetralogy of Fallot (TOF) repair.
  • Complete repair of TOF in infants and children has evolved, with ongoing debate regarding optimal surgical timing and techniques.

Purpose of the Study:

  • To evaluate the safety and efficacy of primary intracardiac repair of tetralogy of Fallot in symptomatic children, irrespective of age or weight.
  • To assess early and late postoperative outcomes, including mortality, RVOT gradients, and residual defects.

Main Methods:

  • A retrospective review of 40 patients undergoing complete repair of TOF between January 1984 and January 1987.
  • Surgical approach involved Dacron patch closure of the ventricular septal defect, minimized infundibular resection, and leaving atrial communications open.
  • Transannular RVOT patch reconstruction was utilized in the majority of patients.

Main Results:

  • No mortality was observed in the 40 patients undergoing intracardiac repair.
  • Postoperative RVOT pullback gradients ranged from 0 to 35 mm Hg (mean 18.5 mm Hg).
  • Follow-up revealed no residual ventricular septal defects and only one moderate RVOT gradient on serial echocardiograms and cardiac catheterization.

Conclusions:

  • Primary intracardiac repair of tetralogy of Fallot is a viable and safe option for symptomatic children, even those who are younger or have lower weights.
  • The use of a transannular RVOT patch does not appear to adversely affect early or late outcomes in this patient cohort.
  • These findings support the continued practice of primary repair for symptomatic tetralogy of Fallot, challenging previous concerns about age and weight limitations.

Related Concept Videos